Form 4: USANA Health Sciences Director Ding Xia Reports RSU Vesting and Share Disposition

USANA Health Sciences Director Ding Xia reported the vesting of 1,058 restricted stock units and the subsequent disposition of 265 shares to cover tax obligations.

Summary

• Director Ding Xia of USANA Health Sciences acquired 1,058 shares of common stock on July 24, 2025, through the exercise of Restricted Stock Units (RSUs).
• Concurrently, 265 shares of common stock were disposed of at a price of $32.09 per share, likely to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Ding Xia directly holds 5,337 shares of common stock and 3,172 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving RSU vesting and tax-related share disposition, which is neutral in terms of company performance or strategic direction.

Positives

• The vesting of Restricted Stock Units indicates a retention and incentive mechanism for the director, aligning their interests with shareholders.

Negatives

• The disposition of 265 shares, while common for tax purposes, represents a reduction in direct shareholding.

Future Outlook

Remaining Restricted Stock Units are scheduled to vest in three additional 25% increments on October 23, 2025, January 22, 2026, and April 23, 2026.

Industry Context

This filing represents a routine insider transaction related to executive compensation, common across publicly traded companies, particularly for directors receiving equity-based awards like Restricted Stock Units.

Comparison to Industry Standards

• The RSU vesting and subsequent share disposition for tax purposes are standard practices for executive compensation in the U.S. market.
• This type of transaction is a common mechanism for directors and executives to realize value from their equity awards while fulfilling tax obligations, aligning with compensation structures seen in comparable health and wellness companies.

Stakeholder Impact

• Shareholders: The transaction is a routine part of director compensation and does not indicate a significant change in company strategy or financial health. It slightly reduces the director's direct shareholding but aligns their long-term interests through remaining RSUs.

Next Steps

• Remaining Restricted Stock Units will vest 25% on October 23, 2025.
• Remaining Restricted Stock Units will vest 25% on January 22, 2026.
• Remaining Restricted Stock Units will vest 25% on April 23, 2026.

Key Dates

Keywords

USANA Health Sciences, USNA, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Director Compensation, Share Disposition, Stock Transaction